查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1697136

全球臨床試驗影像市場：產業分析、規模、佔有率、成長、趨勢和預測（2025-2032）

Clinical Trial Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計 2025 年全球臨床試驗影像市場規模將達到 15 億美元，到 2032 年將達到 25 億美元，預測期內（2025-2032 年）的複合年成長率為 7.5%。

臨床試驗影像是指在臨床試驗中使用醫學成像技術，例如MRI、 電腦斷層掃描、PET掃描和超音波，來評估新藥、新療法和新醫療設備的有效性和安全性。這些顯像模式可幫助研究人員準確診斷疾病、監測治療並識別生物標記。隨著製藥和生物技術公司越來越依賴基於影像的證據來支持監管部門的核准和縮短藥物開發時間，對臨床試驗成像的需求也在不斷成長。

全球臨床試驗影像市場受到幾個關鍵因素的推動，包括臨床研究中擴大採用先進的成像技術。癌症、心血管疾病和神經系統疾病等慢性疾病的盛行率不斷上升，推動了藥物臨床試驗對基於影像的生物標記的需求。此外，全球臨床試驗數量的增加，加上對成像終點的嚴格監管要求，正在推動市場成長。人工智慧 (AI) 和機器學習 (ML) 與成像技術相結合的進步進一步提高了影像分析的準確性並改善了臨床試驗結果。

儘管存在巨大的成長機會，但臨床試驗成像市場仍面臨與顯像模式和基礎設施相關的高成本等挑戰。此外，各地區監理合規的複雜性也是市場拓展的障礙。此外，缺乏擅長解釋和分析影像資料的專家，這使得有效的臨床試驗執行成為一項挑戰。此外，臨床實驗核准的延遲以及不同臨床實驗試驗地點的成像通訊協定的差異也增加了該市場的運作複雜性。

由於雲端基礎的成像解決方案和遠端監控技術的日益普及，臨床試驗成像市場提供了巨大的成長機會。人工智慧影像處理軟體的開發有望增強即時資料處理並實現影像分析的自動化，從而減少人為錯誤。此外，製藥公司、委外研發機構(CRO) 和影像服務供應商之間的策略聯盟有望協助簡化臨床試驗中的影像處理工作流程。新興市場（尤其是亞太地區）臨床試驗的擴展為市場參與者提供了良好的成長前景。

本報告研究了全球臨床試驗影像市場，並根據產品/服務、方式、治療領域、最終用戶、地理位置和公司概況提供了詳細的細分。

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
  • 宏觀經濟因素
  • COVID-19影響分析
  • 預測因子－相關性和影響力

第3章 增值洞察

第4章 2019-2032年價格趨勢分析

第5章全球臨床試驗影像市場展望

  • 主要亮點
  • 市場規模分析及預測
    • 2019-2024 年歷史市場規模分析
    • 2025-2032年目前市場規模分析與預測
  • 全球臨床試驗影像市場（按產品和服務）展望
    • 簡介/主要發現
    • 2019 年至 2024 年按產品/服務分類的歷史市場規模和數量（單位）分析
    • 2025 年至 2032 年按產品和服務分類的當前市場規模和數量（單位）分析與預測
  • 按產品/服務進行市場吸引力分析
  • 全球臨床試驗影像市場展望（按模式）
    • 簡介/主要發現
    • 2019 年至 2024 年按模式分類的歷史市場規模分析
    • 2025 年至 2032 年按模式分類的當前市場規模分析與預測
  • 按模式進行市場吸引力分析
  • 全球臨床試驗影像市場（按治療領域）展望
    • 簡介/主要發現
    • 2019 年至 2024 年按治療領域分類的歷史市場規模分析
    • 2025 年至 2032 年按治療領域分類的當前市場規模分析與預測
  • 市場吸引力分析：治療領域
  • 全球臨床試驗影像市場前景（按最終用戶）
    • 簡介/主要發現
    • 2019 年至 2024 年按最終用戶分類的歷史市場規模和數量（單位）分析
    • 目前市場規模和數量（單位）分析及預測（按最終用戶分類），2025 年至 2032 年

6. 全球臨床試驗影像市場（按地區）展望

  • 主要亮點
  • 2019 年至 2024 年各地區歷史市場規模及銷售量（單位）分析
  • 2025 年至 2032 年各地區當前市場規模及數量（單位）分析及預測
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 按地區分析市場吸引力

7. 北美臨床試驗影像市場展望

8. 歐洲臨床試驗影像市場展望

第9章東亞臨床試驗影像市場展望

10. 南亞和大洋洲臨床試驗影像市場展望

第 11 章拉丁美洲臨床試驗影像市場展望

12.中東和非洲臨床試驗成像市場展望

第13章競爭格局

  • 2025年市場佔有率分析
  • 市場結構
  • 公司簡介（詳情－概述、財務狀況、策略、最新發展）
    • Ixico PLC
    • Navitas Life Sciences
    • Resonance Health
    • Radiant Sage LLC
    • Medpace
    • WCG Clinical
    • Icon PLC
    • Voiant
    • Clario
    • Parexel International Corporation
    • Anagram
    • Calyx
    • Invicro

第14章 附錄

簡介目錄
Product Code: PMRREP35178

Persistence Market Research has recently released a comprehensive report on the worldwide market for clinical trial imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global clinical trial imaging market from 2025 to 2032.

Key Insights:

  • Clinical Trial Imaging Market Size (2025E): US$ 1.5 Bn
  • Projected Market Value (2032F): US$ 2.5 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 7.5%

Clinical Trial Imaging Market - Report Scope:

Clinical trial imaging refers to the use of medical imaging techniques such as MRI, CT scans, PET scans, and ultrasound in clinical trials to assess the efficacy and safety of new drugs, treatments, and medical devices. These imaging modalities help researchers in accurate disease diagnosis, treatment monitoring, and biomarker identification. The demand for clinical trial imaging is rising as pharmaceutical and biotechnology companies increasingly rely on imaging-based evidence to support regulatory approvals and accelerate drug development timelines.

Market Growth Drivers:

The global clinical trial imaging market is driven by several key factors, including the growing adoption of advanced imaging technologies in clinical research. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has fueled the demand for imaging-based biomarkers in drug trials. Moreover, the rising number of clinical trials globally, coupled with stringent regulatory requirements for imaging endpoints, is propelling market growth. Advancements in artificial intelligence (AI) and machine learning (ML) integration with imaging technologies are further enhancing image analysis accuracy, thus improving clinical trial outcomes.

Market Restraints:

Despite significant growth opportunities, the clinical trial imaging market faces challenges such as high costs associated with imaging modalities and infrastructure. The complexity of regulatory compliance in different regions also acts as a barrier to market expansion. Additionally, the shortage of skilled professionals for imaging data interpretation and analysis poses a challenge for efficient clinical trial execution. Delays in trial approvals and the variability in imaging protocols across different study sites further add to the operational complexities of this market.

Market Opportunities:

The clinical trial imaging market presents substantial growth opportunities driven by the increasing adoption of cloud-based imaging solutions and remote monitoring technologies. The development of AI-powered imaging software is expected to enhance real-time data processing and automate image analysis, reducing human errors. Additionally, strategic collaborations between pharmaceutical companies, contract research organizations (CROs), and imaging service providers are expected to streamline clinical trial imaging workflows. The expansion of clinical trials in emerging markets, particularly in Asia-Pacific, offers lucrative growth prospects for market players.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the clinical trial imaging market globally?
  • How does the integration of AI and machine learning enhance imaging capabilities in clinical trials?
  • Which therapeutic areas are leading in the adoption of clinical trial imaging solutions?
  • Who are the key players in the clinical trial imaging market, and what strategies are they employing to gain a competitive advantage?
  • What are the emerging trends and future growth prospects in the global clinical trial imaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global clinical trial imaging market, including BioTelemetry, Parexel International Corporation, ICON plc, Medpace, and Biomedical Systems, focus on technological innovations, strategic partnerships, and service expansion to strengthen their market presence. Companies are investing in AI-driven imaging analysis platforms and cloud-based imaging solutions to improve clinical trial efficiency. Collaborations with pharmaceutical firms and CROs are facilitating the seamless integration of imaging endpoints in drug development studies. The increasing adoption of decentralized trials and remote imaging solutions is also shaping the future of clinical trial imaging, ensuring faster and more cost-effective trial execution.

Key Companies Profiled:

  • Ixico PLC
  • Navitas Life Sciences
  • Resonance Health
  • Radiant Sage LLC
  • Medpace
  • WCG Clinical
  • Icon PLC
  • Voiant
  • Clario
  • Parexel International Corporation
  • Anagram
  • Calyx
  • Invicro

Clinical Trial Imaging Market Segmentation

By Product & Services

  • Services
  • Software

By Modality

  • CT scan
  • MRI
  • X-Ray
  • Ultrasound

By Therapeutic Area

  • Oncology
  • Neurology
  • Cardiology
  • Orthopedics
  • Obstetrics & Gynecology

By End User

  • Contract Research Organizations (CROs)
  • Pharmaceutical & Biotechnology Companies
  • Academic and Government Research Institutes

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Clinical Trial Imaging Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product & Services Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2032

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product & Services Prices
  • 4.3. Pricing Analysis By Product & Services
  • 4.4. Regional Prices and Product & Services Preferences

5. Global Clinical Trial Imaging Market Outlook:

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Clinical Trial Imaging Market Outlook: Product & Services
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product & Services, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
      • 5.3.3.1. Services
      • 5.3.3.2. Software
  • 5.4. Market Attractiveness Analysis: Product & Services
  • 5.5. Global Clinical Trial Imaging Market Outlook: Modality
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2024
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
      • 5.5.3.1. CT scan
      • 5.5.3.2. MRI
      • 5.5.3.3. X-Ray
  • 5.6. Market Attractiveness Analysis: Modality
  • 5.7. Global Clinical Trial Imaging Market Outlook: Therapeutic Area
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2019-2024
    • 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
      • 5.7.3.1. Oncology
      • 5.7.3.2. Neurology
      • 5.7.3.3. Cardiology
      • 5.7.3.4. Orthopedics
      • 5.7.3.5. Obstetrics & Gynecology
  • 5.8. Market Attractiveness Analysis: Therapeutic Area
  • 5.9. Global Clinical Trial Imaging Market Outlook: End User
    • 5.9.1. Introduction / Key Findings
    • 5.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By End User, 2019-2024
    • 5.9.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
      • 5.9.3.1. Contract Research Organizations (CROs)
      • 5.9.3.2. Pharmaceutical & Biotechnology Companies
      • 5.9.3.3. Academic and Government Research Institutes

6. Global Clinical Trial Imaging Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Clinical Trial Imaging Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product & Services
    • 7.2.3. By Modality
    • 7.2.4. By Therapeutic Area
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 7.4.1. Services
    • 7.4.2. Software
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 7.5.1. CT scan
    • 7.5.2. MRI
    • 7.5.3. X-Ray
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 7.6.1. Oncology
    • 7.6.2. Neurology
    • 7.6.3. Cardiology
    • 7.6.4. Orthopedics
    • 7.6.5. Obstetrics & Gynecology
  • 7.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Contract Research Organizations (CROs)
    • 7.7.2. Pharmaceutical & Biotechnology Companies
    • 7.7.3. Academic and Government Research Institutes
  • 7.8. Market Attractiveness Analysis

8. Europe Clinical Trial Imaging Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product & Services
    • 8.2.3. By Modality
    • 8.2.4. By Therapeutic Area
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 8.4.1. Services
    • 8.4.2. Software
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 8.5.1. CT scan
    • 8.5.2. MRI
    • 8.5.3. X-Ray
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 8.6.1. Oncology
    • 8.6.2. Neurology
    • 8.6.3. Cardiology
    • 8.6.4. Orthopedics
    • 8.6.5. Obstetrics & Gynecology
  • 8.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Contract Research Organizations (CROs)
    • 8.7.2. Pharmaceutical & Biotechnology Companies
    • 8.7.3. Academic and Government Research Institutes
  • 8.8. Market Attractiveness Analysis

9. East Asia Clinical Trial Imaging Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product & Services
    • 9.2.3. By Modality
    • 9.2.4. By Therapeutic Area
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 9.4.1. Services
    • 9.4.2. Software
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 9.5.1. CT scan
    • 9.5.2. MRI
    • 9.5.3. X-Ray
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 9.6.1. Oncology
    • 9.6.2. Neurology
    • 9.6.3. Cardiology
    • 9.6.4. Orthopedics
    • 9.6.5. Obstetrics & Gynecology
  • 9.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Contract Research Organizations (CROs)
    • 9.7.2. Pharmaceutical & Biotechnology Companies
    • 9.7.3. Academic and Government Research Institutes
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Clinical Trial Imaging Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product & Services
    • 10.2.3. By Modality
    • 10.2.4. By Therapeutic Area
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 10.4.1. Services
    • 10.4.2. Software
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 10.5.1. CT scan
    • 10.5.2. MRI
    • 10.5.3. X-Ray
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 10.6.1. Oncology
    • 10.6.2. Neurology
    • 10.6.3. Cardiology
    • 10.6.4. Orthopedics
    • 10.6.5. Obstetrics & Gynecology
  • 10.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Contract Research Organizations (CROs)
    • 10.7.2. Pharmaceutical & Biotechnology Companies
    • 10.7.3. Academic and Government Research Institutes
  • 10.8. Market Attractiveness Analysis

11. Latin America Clinical Trial Imaging Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product & Services
    • 11.2.3. By Modality
    • 11.2.4. By Therapeutic Area
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 11.4.1. Services
    • 11.4.2. Software
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 11.5.1. CT scan
    • 11.5.2. MRI
    • 11.5.3. X-Ray
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 11.6.1. Oncology
    • 11.6.2. Neurology
    • 11.6.3. Cardiology
    • 11.6.4. Orthopedics
    • 11.6.5. Obstetrics & Gynecology
  • 11.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Contract Research Organizations (CROs)
    • 11.7.2. Pharmaceutical & Biotechnology Companies
    • 11.7.3. Academic and Government Research Institutes
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Clinical Trial Imaging Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product & Services
    • 12.2.3. By Modality
    • 12.2.4. By Therapeutic Area
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 12.4.1. Services
    • 12.4.2. Software
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 12.5.1. CT scan
    • 12.5.2. MRI
    • 12.5.3. X-Ray
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 12.6.1. Oncology
    • 12.6.2. Neurology
    • 12.6.3. Cardiology
    • 12.6.4. Orthopedics
    • 12.6.5. Obstetrics & Gynecology
  • 12.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Contract Research Organizations (CROs)
    • 12.7.2. Pharmaceutical & Biotechnology Companies
    • 12.7.3. Academic and Government Research Institutes
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Ixico PLC
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product & Services Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Navitas Life Sciences
    • 13.3.3. Resonance Health
    • 13.3.4. Radiant Sage LLC
    • 13.3.5. Medpace
    • 13.3.6. WCG Clinical
    • 13.3.7. Icon PLC
    • 13.3.8. Voiant
    • 13.3.9. Clario
    • 13.3.10. Parexel International Corporation
    • 13.3.11. Anagram
    • 13.3.12. Calyx
    • 13.3.13. Invicro

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations